LIVZON PHARMA 2025 ESG Report: 19.84% CO₂ Cut, 2055 Net-Zero Goal and RMB1.06 Billion R&D Outlay

Bulletin Express03-24

LIVZON PHARMA (01513) released its 2025 Environmental, Social and Governance (ESG) Report, presenting material progress on decarbonisation, innovation spend and talent development.

• Carbon trajectory – Total Scope 1+2 emissions fell 8.00 % year-on-year to 488,612 tonnes of CO₂e, 19.84 % lower than the 2020 baseline. – Emission intensity dropped 23.11 % from 2020; the group reaffirmed its 2055 carbon-neutrality target and set 2026-2030 goals to keep Scope 1+2 emissions per RMB10,000 of output at or below 2025 levels. – Scope 3 emissions were quantified for a second year at 589,700 tonnes of CO₂e, with purchased goods and services contributing 35.39 %.

• Resource efficiency – Water use declined 3.84 % from 2020 to 6.03 million tonnes; intensity improved 8.44 % versus 2020. – Total energy consumption edged down to 150,214 tonnes of standard coal equivalent; renewable energy use reached 78,379 MWh. – Environmental capex and O&M spending totalled RMB72.09 million.

• Innovation pipeline and spending – R&D expenditure rose to RMB1.06 billion, 8.79 % of revenue. – The group lists 17 products in Phase III/registration, including two first-in-class assets; 71 S&P Global CSA score places it in the top 5 % of Chinese peers.

• Supply-chain oversight – ESG audits covered 552 direct suppliers and 5 key indirect suppliers; 100 % of suppliers have signed integrity and ESG commitments.

• Workforce and safety – Employees totalled 8,878; females account for 47.60 % of staff and 38.31 % of management. – Zero work-related fatalities; LTIFR for employees at 0.39 per million hours worked. – Occupational health & safety certification reached 100 % of production sites.

• Social investment – Public-interest donations amounted to RMB30.96 million, with the long-running “Accessible and Affordable Chronic Disease Management” programme reaching 48,000 beneficiaries across 37 regions.

LIVZON PHARMA plans to cut water intensity by 5 % and air-pollutant emissions by 10 % versus 2025 levels by 2030 while maintaining current carbon-intensity gains, aiming to align its operations with the 1.5 °C pathway en route to net-zero emissions by 2055.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment